vTv Therapeutics (VTVT) Research & Development: 2014-2025
Historic Research & Development for vTv Therapeutics (VTVT) over the last 12 years, with Sep 2025 value amounting to $7.0 million.
- vTv Therapeutics' Research & Development rose 117.74% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.2 million, marking a year-over-year increase of 41.37%. This contributed to the annual value of $11.5 million for FY2024, which is 15.07% down from last year.
- vTv Therapeutics' Research & Development amounted to $7.0 million in Q3 2025, which was up 71.09% from $4.1 million recorded in Q2 2025.
- In the past 5 years, vTv Therapeutics' Research & Development ranged from a high of $7.0 million in Q3 2025 and a low of $2.1 million during Q4 2023.
- In the last 3 years, vTv Therapeutics' Research & Development had a median value of $3.2 million in 2024 and averaged $3.6 million.
- Its Research & Development has fluctuated over the past 5 years, first crashed by 46.06% in 2023, then surged by 117.74% in 2025.
- Over the past 5 years, vTv Therapeutics' Research & Development (Quarterly) stood at $5.4 million in 2021, then decreased by 26.62% to $4.0 million in 2022, then crashed by 46.06% to $2.1 million in 2023, then climbed by 4.49% to $2.2 million in 2024, then skyrocketed by 117.74% to $7.0 million in 2025.
- Its last three reported values are $7.0 million in Q3 2025, $4.1 million for Q2 2025, and $2.8 million during Q1 2025.